Pretreatment with Erythropoietin Attenuates Lung Ischemia/Reperfusion Injury via Toll-Like Receptor-4/Nuclear Factor-κB (TLR4/NF-κB) Pathway

BACKGROUND: Lung ischemia/reperfusion injury (LIRI) is a medical problem featuring pulmonary dysfunction and damage. The present study aimed to investigate the protective effects of erythropoietin (EPO), which has been reported to be an anti-inflammatory agent, on LIRI through inhibiting the TLR-4/N...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qian, Zhao, Xueshan, Bi, Siwei, Cao, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Animal Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842661/
https://www.ncbi.nlm.nih.gov/pubmed/29493564
http://dx.doi.org/10.12659/MSM.905690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842661/
https://www.ncbi.nlm.nih.gov/pubmed/29493564
http://dx.doi.org/10.12659/MSM.905690

Ejemplares similares